Dasatinib
Healthy Lifestyle
Cedars-Sinai Medical CenterSmall moleculePhase 2/3Active
B
56/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 41/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Healthy Lifestyle cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
FLAVONE, 3,3',4',5,7-PENTAHYDROXY- Cedars-Sinai Medical Center | Phase 2/3 | B |
Same molecule, other indications
Dasatinib is also rated in:
B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)Dormant
BB
Indicative ·
67 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →